Publication | Closed Access

Oct-4 is required for an antiapoptotic behavior of chemoresistant colorectal cancer cells enriched for cancer stem cells: Effects associated with STAT3/Survivin

OncologyMedicinePharmacologyAntiapoptotic BehaviorColorectal CancerStem Cell ResearchCancer BiologyAnti-cancer AgentStem CellsCell BiologyCancer ResearchTumor BiologyCancer Stem CellsHealth Sciences